Bessemer Group’s Kindred Healthcare KND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-672
| Closed | -$6K | – | 1952 |
|
|
2018
Q2 | $6K | Hold |
672
| – | – | ﹤0.01% | 1556 |
|
|
2018
Q1 | $6K | Sell |
672
-2,308
| -77% | -$21.4K | ﹤0.01% | 1539 |
|
|
2017
Q4 | $29K | Sell |
2,980
-500
| -14% | -$3.72K | ﹤0.01% | 1354 |
|
|
2017
Q3 | $23K | Hold |
3,480
| – | – | ﹤0.01% | 1467 |
|
|
2017
Q2 | $41K | Hold |
3,480
| – | – | ﹤0.01% | 1339 |
|
|
2017
Q1 | $30K | Hold |
3,480
| – | – | ﹤0.01% | 1397 |
|
|
2016
Q4 | $27K | Hold |
3,480
| – | – | ﹤0.01% | 1479 |
|
|
2016
Q3 | $35K | Hold |
3,480
| – | – | ﹤0.01% | 1258 |
|
|
2016
Q2 | $39K | Hold |
3,480
| – | – | ﹤0.01% | 898 |
|
|
2016
Q1 | $43K | Sell |
3,480
-267,140
| -99% | -$2.77M | ﹤0.01% | 927 |
|
|
2015
Q4 | $3.22M | Buy |
270,620
+267,140
| +7,676% | +$3.46M | 0.02% | 333 |
|
|
2015
Q3 | $55K | Hold |
3,480
| – | – | ﹤0.01% | 940 |
|
|
2015
Q2 | $71K | Sell |
3,480
-2,865
| -45% | -$65.6K | ﹤0.01% | 911 |
|
|
2015
Q1 | $151K | Buy |
+6,345
| New | +$129K | ﹤0.01% | 767 |
|
Bessemer Group's KND Position: Q3 2018 in Review
Bessemer Group sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 672 shares — an estimated $6K sold.
Bessemer Group first reported a position in KND in Q1 2015 and held it in 14 quarters. The position peaked at $3.22M in Q4 2015. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.
- Bessemer Group reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
- Bessemer Group sold 672 Kindred Healthcare shares in Q3 2018, an estimated $6K.
- Bessemer Group first reported a position in Kindred Healthcare in Q1 2015 and held it in 14 quarters.
- Bessemer Group's Kindred Healthcare position peaked at $3.22M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.
Based on Bessemer Group's 13F filing for Q3 2018, filed 6 Nov 2018.